American Association for Cancer Research
10780432ccr120270-sup-ccr_12-0270_t2_57k.pdf (57.92 kB)

Supplementary Tables 1-2 from Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population

Download (57.92 kB)
journal contribution
posted on 2023-03-31, 17:16 authored by Nicolas Wentzensen, Lauren Schwartz, Rosemary E. Zuna, Katie Smith, Cara Mathews, Michael A. Gold, R. Andy Allen, Roy Zhang, S. Terence Dunn, Joan L. Walker, Mark Schiffman

PDF file - 57K, Supplementary table 1: Clinical performance of p16/Ki-67, HR-HPV, and HPV16/18 to detect CIN2+ (n=91) or CIN3+ (n=20) for LSIL triage Supplementary table 2: Clinical performance of p16/Ki-67 and HPV16/18 to detect CIN2+ (n=33) or CIN3+ (n=12) for HR-HPV-positive ASC-US triage



Purpose: Cytology-based screening has limited sensitivity to detect prevalent cervical precancers. Human papilloma virus (HPV) DNA testing is highly sensitive and provides a high, long-term reassurance of low risk of cervical cancer. However, the specificity of HPV DNA testing is limited, requiring additional, more disease-specific markers for efficient screening approaches.Experimental Design: Liquid-based cytology samples were collected from 625 women referred to colposcopy. A slide was stained using the CINtec plus cytology assay. Pap cytology and HPV genotyping were conducted from the same vial. Clinical performance characteristics were calculated for all women, stratified by age, and for women referred with a low-grade squamous intraepithelial lesion (LSIL) Pap.Results: p16/Ki-67 positivity increased with histologic severity, from 26.8% in normal histology, 46.5% in CIN1, 82.8% in CIN2 to 92.8% in CIN3. Among women with CIN3, p16/Ki-67 positivity increased from 77.8% for women younger than 30 years without HPV16 to 100% for women 30 years and older with HPV16. The sensitivity and specificity to detect CIN3+ were 93.2% and 46.1%, respectively, and increased to 97.2% and 60.0% among women 30 years and older. In women with high-risk (HR)-HPV–positive atypical squamous cells of undetermined significance (ASC-US) and LSIL, sensitivity and specificity for detection of CIN3 were 90.6% and 48.6%, respectively.Conclusions: p16/Ki-67 testing could reduce referral to colposcopy by almost half while detecting the most severe cases of CIN3. The high sensitivity of p16/Ki-67 with significantly improved specificity compared with HPV testing makes p16/Ki-67 a viable option for LSIL triage. Further studies are required to evaluate p16/Ki-67 as triage marker in HPV-based screening strategies. Clin Cancer Res; 18(15); 4154–62. ©2012 AACR.

Usage metrics

    Clinical Cancer Research



    Ref. manager